SAVIMS

SAVIMS logo white
Menu

Viral illnesses

COVID-19, Covid-19 vaccines, Ethics, Peer-reviewed evidence, Reference Library, Resource Type, Vaccines, Viral illnesses

Censorship and Suppression of COVID-19 Heterodoxy

| | COVID-19, Covid-19 vaccines, Ethics, Peer-reviewed evidence, Reference Library, Resource Type, Vaccines, Viral illnesses

Reference: Shir-Raz, Y., Elisha, E., Martin, B., Ronel, N., & Guetzkow, J. (2022). Censorship and suppression of COVID-19 heterodoxy: Tactics and counter-tactics. Minerva. https://doi.org/10.1007/s11024-022-09479-4 Summary: This article examines the censorship of dissenting medical views on COVID-19 by various authorities and media. It highlights tactics used against prominent doctors and scientists who challenged mainstream narratives, including […]

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Insider Revelations on COVID-19 and US Bioweapons Activity

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Classen, J. B. (2022). COVID-19 and illegal US bioweapons activity, an insider’s revelations. Trends in Internal Medicine, 2(2), 1-11. Summary: Dr. Bart Classen’s article discusses his perspective on alleged illegal bioweapons activities tied to COVID-19, primarily implicating the US and Israeli intelligence, specifically Mossad. Classen, who worked at NIAID/NIH from 1988 to 1991, argues

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Addressing Misinformation in COVID-19 Vaccination

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Malhotra, A. (2022). Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine – Part 2. Journal of Insulin Resistance, 5(1), a72. https://doi.org/10.4102/jir.v5i1.72 Summary: Aseem Malhotra’s article critiques the spread of misinformation surrounding COVID-19 mRNA vaccines, highlighting ethical concerns in medical practice and the failure of public health messaging. He argues

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Curing Misinformation about COVID-19 mRNA Vaccines

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Malhotra, A. (2022). Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine – Part 1. Journal of Insulin Resistance, 5(1), a71. https://doi.org/10.4102/jir.v5i1.71 Summary: In this article, Aseem Malhotra critically examines the COVID-19 mRNA vaccines, particularly the Pfizer-BioNTech vaccine, highlighting concerns regarding their safety and effectiveness. Malhotra reflects on his personal

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19 Vaccines: An Australian Perspective on Safety and Efficacy

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Turni, C., & Lefringhausen, A. (2022). COVID-19 vaccines – An Australian review. Journal of Clinical & Experimental Immunology, 7(3), 491-508. Summary: This review examines the safety and efficacy of COVID-19 mRNA vaccines from an Australian viewpoint. It contrasts initial promises made about the vaccines with actual outcomes, highlighting serious side effects including death, based

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Analysis of Serious Adverse Events Following mRNA COVID-19 Vaccination

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomised trials in adults. Vaccine, 40(40), 5798-5805. https://doi.org/10.1016/j.vaccine.2022.08.036 Summary: This article examines serious adverse events (SAEs) associated with mRNA COVID-19 vaccines (Pfizer and Moderna) reported in

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Cardiac-Related Mortality Following COVID-19 Vaccination in Florida

| | COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: SA “Vaccine” Injury Medico-Legal Study-Group. (2022). Exploring the relationship between all-cause and cardiac-related mortality following COVID-19 vaccination or infection in Florida residents: a self-controlled case series study. Summary: This study investigates the risks of all-cause and cardiac-related mortality following COVID-19 vaccinations among Florida residents. It reveals that all participants who died did so within

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Periodic Safety Update Report on COVID-19 mRNA Vaccine (BNT162b2)

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: BioNTech Manufacturing GmbH. (2022). COVID-19 mRNA vaccine (nucleoside modified) Reporting Period Periodic Safety Update Report (PSUR) 3: 19 December 2021 through 18 June 2022. Summary: The third Periodic Safety Update Report (PSUR) for the COVID-19 mRNA vaccine (BNT162b2), also known as COMIRNATY®, covers data from 19 December 2021 to 18 June 2022. It outlines

Scroll to Top